In the present study, the results elucidated that DNA methylation of RBPMS2 was responsible for its downregulation in GC and promoted tumor progression, suggesting that DNA methylation of RBPMS2 was essential for the diagnosis of GC. This evidence concerns the gene RBPMS2 and gastric cancer.